SCHEMBL14083170

SCHEMBL14083170

COc1cc(NC(=O)c2ccc(-c3ncccc3Cl)cc2NCc2ccccc2)cc(C(F)(F)F)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RXFP1 Q9HBX9 4/20 0.47
▸ KDR P35968 2/20 0.47
▸ TMPRSS4 Q9NRS4 2/20 0.47
▸ TRPV1 Q8NER1 5/20 0.46
▸ ABL1 P00519 1/20 0.45
▸ EGFR P00533 1/20 0.45
▸ CSF1R P07333 1/20 0.45
▸ PDGFRB P09619 1/20 0.45
▸ KIT P10721 1/20 0.45
▸ FLT1 P17948 1/20 0.45
▸ FLT4 P35916 1/20 0.45
▸ RUVBL1 Q9Y265 1/20 0.44
▸ NFKB1 P19838 2/20 0.44
▸ JUN P05412 1/20 0.44
▸ NFKB2 Q00653 1/20 0.44
▸ RELA Q04206 1/20 0.44
▸ ATF1 P18846 1/20 0.42
▸ PARP1 P09874 1/20 0.42
▸ EGLN1 Q9GZT9 1/20 0.41
▸ MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14083333 0.89 RXFP1 (0.49) RXFP1TMPRSS4TRPV1RUVBL1NFKB1
SCHEMBL14083217 0.88 TMPRSS4 (0.52) TMPRSS4TRPV1RUVBL1NFKB1JUN
SCHEMBL14083155 0.87 MAPT (0.50) KDRTRPV1MEN1ALDH1A1LMNA
SCHEMBL14083162 0.87 TRPV1 (0.62) RXFP1KDRTRPV1ABL1EGFR
SCHEMBL14083183 0.84 KDR (0.49) RXFP1KDRTRPV1FLT1LMNA
SCHEMBL14083607 0.84 TRPV1 (0.58) TMPRSS4TRPV1RUVBL1NFKB1JUN
SCHEMBL14083361 0.83 TRPV1 (0.58) TMPRSS4TRPV1RUVBL1NFKB1JUN
SCHEMBL14083179 0.83 KDR (0.55) KDRTRPV1ABL1FLT1MAPT
SCHEMBL14083178 0.83 KMT2A (0.50) KDRMEN1ALDH1A1LMNAMAPT
SCHEMBL14083152 0.83 KDR (0.49) RXFP1KDRTRPV1MEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 RXFP1 1053/4885KDR 2604/4885TMPRSS4 1826/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback